INTERACTION BETWEEN CIRCULATING AMYLOID FIBRIL PROTEIN PRECURSORS AND EXTRACELLULAR TISSUE MATRIX COMPONENTS IN THE PATHOGENESIS OF SYSTEMIC AMYLOIDOSIS

被引:32
作者
HUSBY, G
STENSTAD, T
MAGNUS, JH
SLETTEN, K
NORDVAG, BY
MARHAUG, G
机构
[1] UNIV TROMSO HOSP,DEPT PAEDIAT,N-9012 TROMSO,NORWAY
[2] UNIV OSLO,CTR BIOTECHNOL,OSLO 3,NORWAY
来源
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY | 1994年 / 70卷 / 01期
关键词
D O I
10.1006/clin.1994.1002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Amyloidosis is a heterogenous group of diseases characterized by deposition of a fibrillar, proteinaceous material, amyloid, in various tissues and organs. Increasing knowledge about the different proteins that constitute the amyloid fibrils has made it possible to classify amyloidosis by the fibril protein, which appears more rational than the traditional classification by its clinical expression. A serum protein is the precursor of the amyloid fibril protein in the various systemic forms of amyloidosis. Although the chemical composition of amyloid is presently well known, the pathogenetic processes that convert such proteins into a fibrillar form and lay them down in the tissues are far from clarified. We suggest some pathogenetic mechanisms for amyloid deposition, involving different types of fibril protein, their precursors, the extrafibrillar amyloid P component, glycosaminoglycans, proteoglycans, and calcium with special reference to experimental work front our research group. © 1994 Academic Press. All rights reserved.
引用
收藏
页码:2 / 9
页数:8
相关论文
共 47 条
[1]  
BENSON MD, 1989, METABOLIC BASIS INHE, V2, P2439
[2]   MECHANISMS OF DISEASE - MONOCLONAL IMMUNOGLOBULIN DEPOSITION - AMYLOIDOSIS, LIGHT CHAIN DEPOSITION DISEASE, AND LIGHT AND HEAVY-CHAIN DEPOSITION DISEASE [J].
BUXBAUM, J .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1992, 6 (02) :323-346
[3]   AMYLOIDOSIS [J].
COHEN, AS .
NEW ENGLAND JOURNAL OF MEDICINE, 1967, 277 (11) :574-+
[4]   AMYLOIDOSIS (CONCLUDED) [J].
COHEN, AS .
NEW ENGLAND JOURNAL OF MEDICINE, 1967, 277 (12) :628-&
[5]   AMYLOIDOSIS [J].
COHEN, AS .
NEW ENGLAND JOURNAL OF MEDICINE, 1967, 277 (10) :522-+
[6]  
COOPER JH, 1974, LAB INVEST, V31, P232
[7]  
EULITZ M, 1990, P NATL ACAD SCI USA, V87, P6543
[8]   THE PRIMARY STRUCTURE OF THE VARIABLE REGION OF AN IMMUNOGLOBULIN-IV LIGHT-CHAIN AMYLOID-FIBRIL PROTEIN (AL GIL) [J].
FYKSE, EM ;
SLETTEN, K ;
HUSBY, G ;
CORNWELL, GG .
BIOCHEMICAL JOURNAL, 1988, 256 (03) :973-980
[9]   A NEW FORM OF AMYLOID PROTEIN ASSOCIATED WITH CHRONIC-HEMODIALYSIS WAS IDENTIFIED AS BETA-2-MICROGLOBULIN [J].
GEJYO, F ;
YAMADA, T ;
ODANI, S ;
NAKAGAWA, Y ;
ARAKAWA, M ;
KUNITOMO, T ;
KATAOKA, H ;
SUZUKI, M ;
HIRASAWA, Y ;
SHIRAHAMA, T ;
COHEN, AS ;
SCHMID, K .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1985, 129 (03) :701-706
[10]   AMYLOID DEPOSITS AND AMYLOIDOSIS - THE BETA-FIBRILLOSES .1. [J].
GLENNER, GG .
NEW ENGLAND JOURNAL OF MEDICINE, 1980, 302 (23) :1283-1292